Impact of prior chemotherapy with two different fluoropyrimidines on the efficacy of capecitabine plus irinotecan or FOLFIRI with or without bevacizumab in metastatic colorectal cancer: a post hoc analysis of the AXEPT study.

ABSTRACT:

SUBMITTER: Iwasa S 

PROVIDER: S-EPMC10091100 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature